What attracted you to the health metrics field?
I’ve always been interested in disparities and how environmental, social, and historical factors have played a role in helping some groups to thrive while disadvantaging others. Specifically, I recognize health disparities as having detrimental effects on the longevity and quality of life of disadvantaged groups. What excites me about the health metrics field is the idea of quantifying major health issues by identifying what these issues are, which populations are being most affected, and how we can use resources to help alleviate these issues for these communities and improve population health.
What work are you doing at IHME?
I am working on the Global Burden of Disease study, on the Skin and Digestive Disorders Team. I produce global mortality and morbidity estimates for about 14 skin disorders and four digestive disorders.
How do you think your experience at IHME will contribute to your future work?
My time at IHME is helping me to further my quantitative skills and think critically about new concepts. Not only am I better familiarizing myself with the global health landscape, I’ve also grown tremendously in my ability to code and apply advanced statistical methods. Though I am unsure of my plans post-IHME, I am confident that my time here will fully prepare me as I continue on in my professional career.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1789–858. doi: http://dx.doi.org/10.1016/S0140-6736(18)32279-7.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1859–922. doi: http://dx.doi.org/10.1016/S0140-6736(18)32335-3.